Experimental colitis in rats with portal hypertension and liver disease

Inflammatory Bowel Diseases

Volumn 9, Issue 1, 2003, Pages 18-24

  Ackerman, Zvi ^a   Karmeli, Fanny ^b   Cohen, Patrizia ^c   Rachmilewitz, Daniel ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Experimental colitis; Nitric oxide; Portal hypertension; Prostaglandins

Indexed keywords

ACETIC ACID; AUTACOID; ENDOTHELIN 1; IODOACETAMIDE; LEUKOTRIENE B4; MYELOPEROXIDASE; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; ENZYME ACTIVITY; EXPERIMENTAL RAT; LIVER CIRRHOSIS; LIVER DISEASE; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; TISSUE INJURY; VEIN LIGATION;

ALKYLATING AGENTS; AMINO ACIDS; ANIMALS; BILE DUCTS; COLITIS; DISEASE MODELS, ANIMAL; HEMODYNAMIC PROCESSES; HYPERTENSION, PORTAL; INTESTINAL MUCOSA; IODOACETAMIDE; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS;

EID: 0037239639     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200301000-00003     Document Type: Article

References (36)

1. Rabinowitz M, Schade RR, Dindzans VJ, et al. Colonic disease in cirrhosis. Gastroenterology 1990;99:195-9.
2. Kozarek RA, Botoman VA, Bredfeldt JE, et al. Portal colopathy: prospective study of colonoscopy in patients with portal hypertension. Gastroenterology 1991;101:1192-7.
3. Naveau S, Bedossa P, Poynard T, et al. Portal hypertensive colopathy: a new entity. Dig Dis Sci 1991;36:1774-81.
4. Viggiano TR, Gostout CJ. Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic and histologic features. Am J Gastroenterol 1992;87:944-54.
5. Tam TN, NG WW, Lee SD. Colonic mucosal changes in patients with liver cirrhosis. Gastrointest Endosc 1995;42:408-12.
6. Bresci G, Gambardella L, Parisi G, et al. Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. J Clin Gastroenterol 1998;26:222-7.
7. Sorell WT, Quigley EMM, Jin G, et al. Bacterial translocation in portal hypertensive rats: studies in basal conditions and after exposure to hemorrhagic shock. Gastroenterology 1993;104:1722-6.
8. Ackerman Z, Karmeli F, Amir G, et al. Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension. Liver 1996;16:12-8.
9. Eliakim R, Rachmilewitz D. Inflammatory mediators and the pathogenesis of inflammatory bowel disease. Ital J Gastroenterol 1992;24:361-8.
10. Murch SH, Braegger CP, Sessa WC, et al. High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis. Lancet 1992;339:381-5.
11. Wiest R, Shah V, Sessa WC, et al. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol 1999;276:GlO43-51.
12. Niederberger M, Gines P, Martin PY, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 1096;24: 947-51.
13. Cahill PA, Redmond EM, Hodges R, et al. Increased endothelial nitric oxide synthase activity in hyperemic vessels of portal hypertensive rats. J Hepatol 1996;25:370-8.
14. Morales-Ruiz M, Jimenez W, Perez-Sala D, et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 1996;24:1481-6.
15. Ohta M, Kaviani A, Tarnawski A, et al. Portal hypertension triggers local activation of inducible nitric oxide synthase gene in colonic mucosa: a key to portal hypertensive colopathy. Gastroenterology 1996;110:A1408.
16. Gadano AC, Songi P, Heller J, et al. Vascular nitric oxide production during the development of two experimental models of portal hypertension. J Hepatol 1999;30:896-903.
17. Rachmilewitz; D, Stamler JS, Karmeli F, et al. Peroxynitrite induces rat colitis: a new model of colonic inflammation. Gastroenterology 1993;105:1681-8.
18. Rachmilewitz D, Karmeli F, Okon E. Sulfhydryl blocker induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology 1995;109:98-106.
19. Rachmilewitz D, Karmeli F, Okon E, et al. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995;37:247-55.
20. Ohta M, Tanoue K, Tarnawski AS, et al. Overexpressed nitric oxide synthase in portal hypertensive stomach of rat: a key to increased susceptibility to damage? Gastroenterology 1997;112: 1920-30.
21. Ohta M, Kaviani A, Tarnawski A, et al. Portal hypertensive colonic mucosa has increased susceptibility to injury: effect mediated by overexpression of endothelin-1. Gastroenterology 1996;110: A1284.
22. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
23. Rachmilewitz D, Eliakim R, Ackerman Z, et al. Colonic endothelin-1 immunoreactivity in active ulcerative colitis. Lancet 1992; 339:1062.
24. Kubes P, McCafferty DM. Nitric oxide and intestinal inflammation. Am J Med 2000;109:150-8.
25. Wallace JL, Miller MJS. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000;119:512-20.
26. Wallace JL, Vergnolle N, Muscara MN, et al. Enhanced anti-inflammatory effects of nitric oxide-releasing derivate of mesalamine in rats. Gastroenterology 1999;117:557-66.
27. Muscara MN, Wallace JL. Nitric oxide, V: therapeutic potential of nitric oxide donors and inhibitors. Am J Physiol 1999;276: G1313-6.
28. Fernandez M, Garcia-Pagan JC, Casadevall M, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal hypertensive rats. Gastroenterology 1995;108:1487-95.
29. Elson CO, Sartor BR, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
30. Yamada T, Marshall S, Speciam RD, et al. A comparative analysis of two models of colitis in rats. Gastroenterology 1992;102: 1524-34.
31. Smith JW, Castro GA. Relation of myeloperoxidase activity in gut mucosa to inflammation. Am J Physiol 1978;234:R72-9.
32. Swain MG, Tjandra K, Kanwar S, et al. Neutrophil adhesion is impaired in a rat model of cholestasis. Gastroenterology 1995;109: 923-32.
33. Roughneen PTM, Drath DB, Kulkarni AD, et al. Impaired non-specific cellular immunity in experimental cholestasis. Ann Surg 1987;206:578-82.
34. Roughneen PTM, Drath DB, Kulkarni AD, et al. Inflammatory cell function in young rodents with experimental cholestasis: investigations of functional deficits, their etiology and then reversibility. J Pediatr Surg 1989;24:668-73.
35. Levy R, Schlaeffer F, Keynan A, et al. Increased neutrophil function induced by bile duct ligation in a rat model. Hepatology 1993; 17:908-14.
36. 4 synthesis by neutrophils in cirrhosis. Gastroenterology 1993;105:170-7.